194 related articles for article (PubMed ID: 10207667)
1. Molecular assessment of clonality leads to the identification of a new germ line TP53 mutation associated with malignant cystosarcoma phyllodes and soft tissue sarcoma.
Bot FJ; Sleddens HF; Dinjens WN
Diagn Mol Pathol; 1998 Dec; 7(6):295-301. PubMed ID: 10207667
[TBL] [Abstract][Full Text] [Related]
2. Evidence for transformation of fibroadenoma of the breast to malignant phyllodes tumor.
Hodges KB; Abdul-Karim FW; Wang M; Lopez-Beltran A; Montironi R; Easley S; Zhang S; Wang N; MacLennan GT; Cheng L
Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):345-50. PubMed ID: 19276971
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate.
McCarthy RP; Zhang S; Bostwick DG; Qian J; Eble JN; Wang M; Lin H; Cheng L
Am J Pathol; 2004 Oct; 165(4):1395-400. PubMed ID: 15466403
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays.
Wang ZC; Buraimoh A; Iglehart JD; Richardson AL
Breast Cancer Res Treat; 2006 Jun; 97(3):301-9. PubMed ID: 16791486
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Molecular and Biological Characteristics of Phyllodes Tumors of the Breast.
Vorotnikov IK; Vysotskaya IV; Denchik DA; Letyagin VP; Davydov MM; Kirsanov VY; Kim EA; Buseva VS
Bull Exp Biol Med; 2020 Oct; 169(6):806-810. PubMed ID: 33098518
[TBL] [Abstract][Full Text] [Related]
6. Clonal analysis of fibroadenoma and phyllodes tumor of the breast.
Noguchi S; Motomura K; Inaji H; Imaoka S; Koyama H
Cancer Res; 1993 Sep; 53(17):4071-4. PubMed ID: 8395336
[TBL] [Abstract][Full Text] [Related]
7. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
8. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract][Full Text] [Related]
9. Possible association between tumor-suppressor gene mutations and hMSH2/hMLH1 inactivation in alveolar soft part sarcoma.
Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Sakamoto A; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2003 Sep; 34(9):841-9. PubMed ID: 14562278
[TBL] [Abstract][Full Text] [Related]
10. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast.
Kleer CG; Giordano TJ; Braun T; Oberman HA
Mod Pathol; 2001 Mar; 14(3):185-90. PubMed ID: 11266524
[TBL] [Abstract][Full Text] [Related]
11. Two germ-line mutations affecting the same nucleotide at codon 257 of p53 gene, a rare site for mutations.
Mazoyer S; Lalle P; Moyret-Lalle C; Marçais C; Schraub S; Frappaz D; Sobol H; Ozturk M
Oncogene; 1994 Apr; 9(4):1237-9. PubMed ID: 8134127
[TBL] [Abstract][Full Text] [Related]
12. Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression.
Piscuoglio S; Ng CK; Murray M; Burke KA; Edelweiss M; Geyer FC; Macedo GS; Inagaki A; Papanastasiou AD; Martelotto LG; Marchio C; Lim RS; Ioris RA; Nahar PK; Bruijn ID; Smyth L; Akram M; Ross D; Petrini JH; Norton L; Solit DB; Baselga J; Brogi E; Ladanyi M; Weigelt B; Reis-Filho JS
J Pathol; 2016 Mar; 238(4):508-18. PubMed ID: 26832993
[TBL] [Abstract][Full Text] [Related]
13. Soft tissue sarcoma metastasis from clonal expansion of p53 mutated tumor cells.
Pollock RE; Lang A; Luo J; El-Naggar AK; Yu D
Oncogene; 1996 May; 12(9):2035-9. PubMed ID: 8649865
[TBL] [Abstract][Full Text] [Related]
14. p53 protein expression and gene mutation in phyllodes tumors of the breast.
Gatalica Z; Finkelstein S; Lucio E; Tawfik O; Palazzo J; Hightower B; Eyzaguirre E
Pathol Res Pract; 2001; 197(3):183-7. PubMed ID: 11314782
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
[TBL] [Abstract][Full Text] [Related]
16. Practical aspects in the diagnosis and management of cystosarcoma phyllodes.
Hart J; Layfield LJ; Trumbull WE; Brayton D; Barker WF; Giuliano AE
Arch Surg; 1988 Sep; 123(9):1079-83. PubMed ID: 2843145
[TBL] [Abstract][Full Text] [Related]
17. p53 and Ki-67 expression as prognostic factors in cystosarcoma phyllodes.
Erhan Y; Zekioglu O; Ersoy O; Tugan D; Aydede H; Sakarya A; Kapkaç M; Ozdemir N; Ozbal O; Erhan Y
Breast J; 2002; 8(1):38-44. PubMed ID: 11856160
[TBL] [Abstract][Full Text] [Related]
18. Tubular carcinoma developing within a recurring cystosarcoma phyllodes of the breast.
Leong AS; Meredith DJ
Cancer; 1980 Oct; 46(8):1863-7. PubMed ID: 6253046
[TBL] [Abstract][Full Text] [Related]
19. Stromal neoplasms of the breast: a comparative flow cytometric study.
El-Naggar AK; Mackay B; Sneige N; Batsakis JG
J Surg Oncol; 1990 Jul; 44(3):151-6. PubMed ID: 2164618
[TBL] [Abstract][Full Text] [Related]
20. Invasive ductal breast cancer within a malignant phyllodes tumor: case report and assessment of clonality.
Macher-Goeppinger S; Marme F; Goeppert B; Penzel R; Schirmacher P; Sinn HP; Aulmann S
Hum Pathol; 2010 Feb; 41(2):293-6. PubMed ID: 19896695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]